GTC Biotherapeutics (fka GTCB)

[n4807g]

Just waiting for validation that the platform will be utilized by other pharmaceutical manufacturers. I believe that this is the key that will unlock the intrinsic value in GTCB. Perhaps it's a poor comparison but I followed CELG for years and misjudged the long term value of their products. I traded it on occasion but looked at the company as a trading opportunity. I think the technology that GTCB has is compelling, I'm willing to hold and see what develops. One thing is for certain, it's either a long term winner or a dog. At a buck it's a risk worth taking. I've bought several times in the last three years and have 35,000 shares and have a cost basis of $1.28. So it's a buck-twenty eight for me ;)

If they announce a partnership with a large pharmaceutical manufacturer and the stock doesn't move, I'll become wary.

If GTCB is even remotely successful (CELG) we will all be well compensated for our patience.